Physician

Alberto Jose Montero, MD

According to 2025 Medicare claims, Alberto Montero, MD (NPI: 1962510826) practices medical oncology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is UNIVERSITY HOSPITALS MEDICAL GROUP INC (NPI: 1669499414; TIN: 204881619) and primary practice location at 44106-1716. Montero is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Montero's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 98 traditional Medicare patients, billed 275 HCPCS/CPT codes, and received $21,825 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 319 prescription claims across 78 beneficiaries totaling $1,434,995 in drug costs, led by Ibrance (Palbociclib). DME data shows 53 claims. Open Payments data shows 44 records totaling $154,008. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $25,170 to $21,825. In contrast, Part D prescription costs have risen steadily, from $126,486 to $1,434,995. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$28K$56K2015 Medicare payment: $25,170 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $27,786 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $35,644 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $56,303 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $35,595 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $18,457 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $20,213 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $18,216 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $20,999 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $21,825 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015111330$25,170
2016112313$27,786
2017134391$35,644
2018184568$56,303
2019172420$35,595
2020119243$18,457
202193273$20,213
2022104285$18,216
2023104259$20,999
202498275$21,825

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.7M2015 Drug cost: $126,486 (USD; Tot_Drug_Cst)2016 Drug cost: $247,887 (USD; Tot_Drug_Cst)2017 Drug cost: $92,971 (USD; Tot_Drug_Cst)2018 Drug cost: $174,121 (USD; Tot_Drug_Cst)2019 Drug cost: $321,259 (USD; Tot_Drug_Cst)2020 Drug cost: $789,593 (USD; Tot_Drug_Cst)2021 Drug cost: $2,243,603 (USD; Tot_Drug_Cst)2022 Drug cost: $3,746,350 (USD; Tot_Drug_Cst)2023 Drug cost: $2,895,653 (USD; Tot_Drug_Cst)2024 Drug cost: $1,434,995 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201558419$126,486
201670478$247,887
201780408$92,971
2018102585$174,121
2019118604$321,259
2020120476$789,593
202192474$2,243,603
2022111694$3,746,350
2023114544$2,895,653
202478319$1,434,995

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.8K$7.5K2019 Medicare payment: $4,248 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,304 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $4,472 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,097 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $7,522 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,237 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R30$4,248
2020N/R17$2,304
2021N/R81$4,472
2022N/R24$1,097
2023N/R61$7,522
2024N/R53$1,237

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more4682$103
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1456$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4575$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1616$34
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's1921$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib742,051$1,157,857
KisqaliRibociclib Succinate11308$152,998
ExemestaneExemestane201,320$6,009
AnastrozoleAnastrozole674,370$588
PregabalinPregabalin14420$570

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R23$741
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R19$358
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R11$138

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$9,818Gilead Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.30$144,190Genmab U.S., Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alberto Jose Montero, MD?

Tedicare shows public-source Medicare data for Alberto Jose Montero, MD (NPI 1962510826), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alberto Jose Montero, MD have ACO affiliation data?

Alberto Jose Montero, MD is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Alberto Jose Montero, MD?

Alberto Jose Montero, MD is linked to UNIVERSITY HOSPITALS MEDICAL GROUP INC (billing NPI 1669499414) in the available physician profile data.

Does Alberto Jose Montero, MD have Open Payments data?

Alberto Jose Montero, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.